Medicine library

Browse medicines

Some records contain detailed evidence; others currently contain only basic identity and regulatory information. Reviewed conclusions appear only when they are available for a specific use and group of people.

Showing 1–17 of 17 records

Semaglutide (Ozempic / Wegovy / Rybelsus)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, obesity, and heart and kidney risk that comes with them
Melanotan II (No trade name; sold as MT-II or MT2, by injection and as a nasal spray)
Peptide medicineControlled substance; no approved US useDetailed record
Use listed on the medicine record
Tanning without sun — unlicensed everywhere, with no approved use
Desmopressin (DDAVP / Stimate / Nocdurna / Noctiva)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Passing far too much urine because the body is missing the hormone that concentrates it — and, separately, bleeding in mild haemophilia A or mild von Willebrand disease
Ipamorelin (Also written NNC 26-0161. No trade name; never marketed)
Peptide medicineIn Phase 2 testingDetailed record
Use listed on the medicine record
A growth hormone releaser designed to leave cortisol alone — never approved
Epitalon (Also written Epithalon and AEDG peptide. Distinct from Epithalamin, the bovine pineal extract it was derived from)
Peptide medicineLaboratory or animal-stage researchDetailed record
Use listed on the medicine record
A four-amino-acid anti-ageing peptide with no clinical trial anywhere
Liraglutide (Victoza / Saxenda)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes and long-term weight management
Dulaglutide (Trulicity)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, including in people who have not yet had a heart attack
Exenatide (Byetta / Bydureon / Bydureon BCise)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes
Teriparatide (Forteo / Bonsity)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Severe bone thinning, where the aim is to build new bone rather than only slow its loss
Tirzepatide (Mounjaro / Zepbound)
Peptide medicineApproved in the United States (FDA)Detailed record
Use listed on the medicine record
Type 2 diabetes, obesity, and obesity-related sleep apnoea
Retatrutide (LY3437943 (no trade name; not approved))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Obesity and type 2 diabetes, still in trials
Sermorelin (Geref, Geref Diagnostic (both discontinued))
Peptide medicineWithdrawn from the marketDetailed record
Use listed on the medicine record
A childhood growth drug that was approved, then pulled — now compounded for anti-ageing
Survodutide (BI 456906 (no trade name; not approved))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Obesity and fatty liver disease, still in trials
CJC-1295 (CJC-1295 with DAC. The product sold as "CJC-1295 without DAC" is a different molecule, modified GRF(1-29))
Peptide medicineIn Phase 2 testingDetailed record
Use listed on the medicine record
Raises growth hormone for a week per injection — no approved use anywhere
Selank (Selank; the peptide is written Thr-Lys-Pro-Arg-Pro-Gly-Pro)
Peptide medicineDietary supplement; not FDA-approved as a medicineDetailed record
Use listed on the medicine record
A Russian anti-anxiety peptide, sold elsewhere as a nasal spray research chemical
TB-500 (thymosin beta-4) (Sold as TB-500. The full peptide is thymosin beta-4, developed as RGN-259 (eye drops) and NL005 (recombinant injection))
Peptide medicineIn Phase 3 testingDetailed record
Use listed on the medicine record
Sold for injury repair — nothing containing it is approved anywhere
Semax (Semax; the peptide is written ACTH(4-7)PGP or Met-Glu-His-Phe-Pro-Gly-Pro)
Peptide medicineDietary supplement; not FDA-approved as a medicineDetailed record
Use listed on the medicine record
A Russian stroke and nootropic peptide, sold elsewhere as a nasal spray research chemical

Semaglutide (Ozempic / Wegovy / Rybelsus)

Melanotan II (No trade name; sold as MT-II or MT2, by injection and as a nasal spray)

Desmopressin (DDAVP / Stimate / Nocdurna / Noctiva)

Ipamorelin (Also written NNC 26-0161. No trade name; never marketed)

Epitalon (Also written Epithalon and AEDG peptide. Distinct from Epithalamin, the bovine pineal extract it was derived from)

Liraglutide (Victoza / Saxenda)

Dulaglutide (Trulicity)

Exenatide (Byetta / Bydureon / Bydureon BCise)

Teriparatide (Forteo / Bonsity)

Tirzepatide (Mounjaro / Zepbound)

Retatrutide (LY3437943 (no trade name; not approved))

Sermorelin (Geref, Geref Diagnostic (both discontinued))

Survodutide (BI 456906 (no trade name; not approved))

CJC-1295 (CJC-1295 with DAC. The product sold as "CJC-1295 without DAC" is a different molecule, modified GRF(1-29))

Selank (Selank; the peptide is written Thr-Lys-Pro-Arg-Pro-Gly-Pro)

TB-500 (thymosin beta-4) (Sold as TB-500. The full peptide is thymosin beta-4, developed as RGN-259 (eye drops) and NL005 (recombinant injection))

Semax (Semax; the peptide is written ACTH(4-7)PGP or Met-Glu-His-Phe-Pro-Gly-Pro)